Clinical trials
Recruiting Phase 2/3 trials in Saudi Arabia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mansoura University | 2 |
| Crinetics Pharmaceuticals Inc. | 1 |
| Kyverna Therapeutics | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Ministry of Health, Saudi Arabia | 1 |
| Pfizer | 1 |
| Resverlogix Corp | 1 |
| Roaa Ahmed Alkreadees | 1 |
| St. Anna Kinderkrebsforschung | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adrenal Hyperplasia, Congenital | 1 |
| Anemia, Sickle Cell | 1 |
| Autoimmune Diseases | 1 |
| Bronchopulmonary Dysplasia | 1 |
| Hashimoto Disease | 1 |
| Heart Failure | 1 |
| Inflammation | 1 |
| Myasthenia Gravis | 1 |
| Post-Acute COVID-19 Syndrome | 1 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.